Harvey, 2020 - Google Patents
Cytolytic toxinsHarvey, 2020
- Document ID
- 8550061560587616309
- Author
- Harvey A
- Publication year
- Publication venue
- Handbook of toxinology
External Links
Snippet
This chapter summarizes information about cytolytic toxins. All cells have plasma membranes that act as a barrier between the internal environment of the cell and the extracellular fluid. It follows, therefore, that all cells are potential targets for cytolytic toxins …
- 239000003053 toxin 0 title abstract description 376
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Harvey | Cytolytic toxins | |
Shier | Handbook of toxinology | |
Dean | Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover | |
Nagamune et al. | Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess | |
Butterworth | The eosinophil and its role in immunity to helminth infection | |
Banks et al. | Chemistry and pharmacology of honey-bee venom | |
Olivera et al. | Peptide neurotoxins from fish-hunting cone snails | |
Warren et al. | Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor | |
ES2586125T3 (en) | Staphylococcus aureus polypeptides and methods of use | |
CN102203127B (en) | Leucoagglutinin and its application | |
Thiagarajan et al. | In vitro attachment and invasion of chicken ovarian granulosa cells by Salmonella enteritidis phage type 8 | |
JPH04506510A (en) | Use of bactericidal/permeability-enhancing proteins or biologically active analogs thereof to treat lipopolysaccharide-associated gram-negative bacterial infections | |
DE69133485T2 (en) | Use of Staphylococcal Enterotoxin Homologs for Cancer Therapy | |
IBRAHIM et al. | Reproductive tract secretions and bull spermatozoa contain different clusterin isoforms that cluster cells and inhibit complement‐induced cytolysis | |
Boutin et al. | Demonstration of invasiveness of Vibrio parahaemolyticus in adult rabbits by immunofluorescence | |
DE69329337T2 (en) | ANTIBIOTIC CRYPTDINPEPTIDE AND METHODS OF USE | |
Page et al. | Biosynthesis and glycosylation of serine/threonine-rich secreted proteins from Toxocara canis larvae | |
Coe | Homologs of CRP: a diverse family of proteins with similar structure | |
Tosteson | Mechanism of action, pharmacology, and toxicology | |
Wu | Pharmacological actions of palytoxin | |
Minnick et al. | Tissue site and modification of a bacteria-induced coagulation protein from Manduca sexta | |
Narat et al. | The humoral and cellular immune response to a lipid attenuated pore-forming toxin from the sea anemone Actinia equina L. | |
Weed et al. | Phenyl-Mercuric Compounds: Their Action on Animals and Their Preservative Values | |
CHUN | Functional & structural studies of Stonustoxin (SNTX), a lethal factor from Stonefish (Synanceja Horrida) venom | |
JP4810638B2 (en) | Antibacterial oligosaccharide and method for producing the same |